Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP): A Prospective Cohort Study

NCT03566797 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT03566797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03566797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP): A Prospective Cohort Study
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Active, not recruiting
Start date
July 20, 2018
Completion date
December 31, 2029
Enrollment
380 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary sclerosis cholangitis in critically ill patients